undamentalytics Newsletter

Alvino Mark: insider trades

Director at Abeona Therapeutics Inc. No open-market purchases and 13 sales not made under a pre-set plan, reported from September 29, 2023 to September 1, 2026.

What happened after Alvino Mark’s sales?

After their sales, the shares moved −22.3% against the index over 12 months on average (a negative figure means selling was the right call); 80% trailed it.

With 296 insiders tested, some will look skilled or unskilled by chance alone: when we replaced each insider’s stocks with random companies bought on the same days, about 5.7 cleared the bar ahead and 23.3 behind. One record on its own proves little.

Trade by trade

Alvino Mark: trades against the S&P 500 afterwards
MeasuredTrades countedAverage vs S&P 500MedianWent the right wayYearst-statisticp-valueEvidence
Purchases, 3 months after the report 0 — — — — — — Not enough years
Purchases, 6 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the trade 0 — — — — — — Not enough years
Sales, 3 months after the report 8 +6.0% +5.1% 25% 2 — — Not enough years
Sales, 12 months after the report 5 −22.3% −23.8% 80% 1 — — Not enough years
Sales, 12 months after the trade 5 −22.7% −22.9% 100% 1 — — Not enough years

“Average vs S&P 500” is the stock’s return including dividends minus the index’s over the same dates, from the close on the first trading day after the report, or from the close on the trade date. Only windows that have finished are counted. For sales, a negative figure means the stock lagged after it was sold, so selling was the right call (green). “Went the right way” is the share of purchases that beat the index, or of sales that trailed it. The t-statistic uses one average per year of reports, because one person’s trades bunch into the same stock and weeks, and needs trades in at least four different years; the p-value comes from the t distribution with that number of years (with four years, a t of 2 has p = 0.14). “Some evidence” means p under 5%, “strong evidence” p under 1% over at least six years.

Companies traded

CompanyTitle on the latest filingPurchasesSalesFirst reportLatest report
Abeona Therapeutics Inc. ABEO —013September 29, 2023September 1, 2026

Trades and what followed

Moves are against the S&P 500; green means the trade went the insider’s way.

ReportedTradedCompanyTradeValue3 months after report12 months after report12 months after trade
September 1, 2026September 1, 2026 ABEO Sale $87,900 not yetnot yetnot yet
May 22, 2026May 22, 2026 ABEO Sale $35,490 +10.8%not yetnot yet
February 2, 2026February 2, 2026 ABEO Sale $10,180 +5.4%not yetnot yet
January 21, 2026January 21, 2026 ABEO Sale $70,605 −0.1%not yetnot yet
November 14, 2025November 13, 2025 ABEO Sale $71,100 not yetnot yetnot yet
July 10, 2025July 9, 2025 ABEO Sale $76,725 −9.3%+1.1%−2.6%
May 27, 2025May 27, 2025 ABEO Sale $12,760 +4.8%−33.7%−34.7%
May 16, 2025May 16, 2025 ABEO Sale $45,440 +1.9%−40.6%−41.0%
January 31, 2025January 29, 2025 ABEO Sale $21,520 +21.8%−23.8%−22.9%
January 21, 2025January 21, 2025 ABEO Sale $20,400 +13.0%−14.6%−12.3%
June 20, 2024June 18, 2024 ABEO Sale $116,764 not yetnot yetnot yet
January 22, 2024January 17, 2024 ABEO Sale $36,199 not yetnot yetnot yet
September 29, 2023September 27, 2023 ABEO Sale $24,696 not yetnot yetnot yet

Open-market purchases and sales of at least $10,000 in companies we cover, from SEC Form 4 filings; sales made under a pre-set Rule 10b5-1 plan are not shown. “Not yet” means the window has not finished or the share price was under $5 at entry. These are the shares’ moves after each trade: they say nothing about why Alvino Mark traded and do not suggest the use of non-public information. How every insider compares · the insider trading backtest.